Developing Novel Conjugate HIV-1 Subunit Therapeutic Vaccines
Abstract
Highly pure, native preparations of recombinant gp120 have been obtained from the T-tropic HIV-l(LAI) and the macrophage-tropic HIV-l(JR-FL) isolates. Conjugates of these HIV-l gp120 preparations were prepared with tetanus toxoid (TT) and keyhole limpet hemocyanin (KHL) with the hypothesis that very immunogenic carrier proteins will increase the immunogenicity of gp 120.
Document Details
- Document Type
- Technical Report
- Publication Date
- Jun 01, 1997
- Accession Number
- ADA330147
Entities
People
- Luis D. Giavedoni
Organizations
- Texas Biomedical Research Institute